RxSight, Inc. (RXST) Tops Q2 EPS by 25c

RxSight, Inc. (NASDAQ: RXST) reported Q2 EPS of ($0.11), $0.25 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $33.74 million versus the consensus estimate of $32.21 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Goldman Sachs Downgrades Schindler Holding AG (SCHN:SW) (SHLAF) to Sell
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight